Home › NDC Lookup › RxCUI directory › RxCUI 310434

Gabapentin 800 MG Oral Tablet — RxCUI 310434

RxNorm drug concept · Semantic clinical drug
RxCUI 310434 Semantic clinical drug · SCD ● Current RxNorm concept 134 FDA products 400 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI310434
Official nameGabapentin 800 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped134
Package NDCs mapped400
Reported Medicaid activity (SDUD)3,153,612 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Gabapentin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Gabapentin is mainly used for two things: managing nerve pain that lingers after a shingles infection (called postherpetic neuralgia) in adults, and helping control partial onset s...
  • This is a really important question. Taking gabapentin together with opioids like morphine, hydrocodone, or oxycodone significantly raises the risk of serious breathing problems —...
  • Can I take gabapentin with my opioid pain medication?
  • The most common ones — especially in the first few weeks — are dizziness, drowsiness, and sometimes loss of balance or coordination. Swelling in the feet or hands is also fairly co...
📖 Read our full Gabapentin guide →

🕸️ Concept Web — How Gabapentin 800 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Gabapentin 800 MG Oral Tablet RxCUI 310434

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Gabapentin 25480
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Neurontin 196498
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Gabapentin Oral Tablet 378099
    • Gabapentin Oral Product 1156681
    • Gabapentin Pill 1156682
    • Gabapentin Oral Tablet [Neurontin] 368227
    • Neurontin Oral Product 1182285
    • Neurontin Pill 1182286
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Gabapentin 800 MG SCDC · 346146
  • Gabapentin Oral Tablet SCDF · 378099
  • Gabapentin Oral Product SCDG · 1156681
  • Gabapentin Pill SCDG · 1156682

Brand-Name Concepts

  • Gabapentin 800 MG Oral Tablet [Neurontin] SBD · 261281
  • Gabapentin 800 MG [Neurontin] SBDC · 574508
  • Gabapentin Oral Tablet [Neurontin] SBDF · 368227
  • Neurontin Oral Product SBDG · 1182285
  • Neurontin Pill SBDG · 1182286
  • Neurontin BN · 196498

📦 FDA Products & Package NDCs

134 products · 400 package NDCs
400 package NDCs map to RxCUI 310434 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
71610-0778-92 270 TABLET in 1 BOTTLE (71610-778-92) Gabapentin Aphena Pharma Solutions - Tennessee, LLC 2024-01-25
72162-1531-01 100 TABLET in 1 BOTTLE (72162-1531-1) Gabapentin Bryant Ranch Prepack 2018-08-20
72162-1531-05 500 TABLET in 1 BOTTLE (72162-1531-5) Gabapentin Bryant Ranch Prepack 2018-08-20
72162-2142-01 100 TABLET, FILM COATED in 1 BOTTLE (72162-2142-1) Gabapentin Bryant Ranch Prepack 2023-10-12
72162-2142-05 500 TABLET, FILM COATED in 1 BOTTLE (72162-2142-5) Gabapentin Bryant Ranch Prepack 2023-10-12
72189-0092-90 90 TABLET, FILM COATED in 1 BOTTLE (72189-092-90) GABAPENTIN DIRECT RX 2020-05-15
72189-0109-30 30 CAPSULE in 1 BOTTLE (72189-109-30) GABAPENTIN DIRECT RX 2020-06-12
72189-0109-60 60 CAPSULE in 1 BOTTLE (72189-109-60) GABAPENTIN DIRECT RX 2020-06-12
72189-0109-72 120 CAPSULE in 1 BOTTLE (72189-109-72) GABAPENTIN DIRECT RX 2020-06-12
72189-0109-90 90 CAPSULE in 1 BOTTLE (72189-109-90) GABAPENTIN DIRECT RX 2020-06-12
72189-0113-30 30 CAPSULE in 1 BOTTLE (72189-113-30) GABAPENTIN DIRECT RX 2020-10-15
72189-0113-60 60 CAPSULE in 1 BOTTLE (72189-113-60) GABAPENTIN DIRECT RX 2020-10-15
72189-0113-72 120 CAPSULE in 1 BOTTLE (72189-113-72) GABAPENTIN DIRECT RX 2020-10-15
72189-0113-90 90 CAPSULE in 1 BOTTLE (72189-113-90) GABAPENTIN DIRECT RX 2020-10-15
72189-0158-30 30 TABLET, FILM COATED in 1 BOTTLE (72189-158-30) GABAPENTIN DIRECT RX 2020-12-01
72189-0158-60 60 TABLET, FILM COATED in 1 BOTTLE (72189-158-60) GABAPENTIN DIRECT RX 2020-12-01
72189-0158-72 120 TABLET, FILM COATED in 1 BOTTLE (72189-158-72) GABAPENTIN DIRECT RX 2020-12-01
72189-0158-90 90 TABLET, FILM COATED in 1 BOTTLE (72189-158-90) GABAPENTIN DIRECT RX 2020-12-01
72189-0178-30 30 TABLET in 1 BOTTLE (72189-178-30) GABAPENTIN DIRECT RX 2021-02-08
72189-0178-72 120 TABLET in 1 BOTTLE (72189-178-72) GABAPENTIN DIRECT RX 2021-02-08
72189-0178-90 90 TABLET in 1 BOTTLE (72189-178-90) GABAPENTIN DIRECT RX 2021-02-08
72189-0394-30 30 TABLET in 1 BOTTLE (72189-394-30) Gabapentin Direct_Rx 2022-11-16
72189-0394-60 60 TABLET in 1 BOTTLE (72189-394-60) Gabapentin Direct_Rx 2022-11-16
72189-0394-72 120 TABLET in 1 BOTTLE (72189-394-72) Gabapentin Direct_Rx 2022-11-16
72189-0394-90 90 TABLET in 1 BOTTLE (72189-394-90) Gabapentin Direct_Rx 2022-11-16
72189-0619-72 120 TABLET in 1 BOTTLE (72189-619-72) Gabapentin Direct_Rx 2025-03-18
72189-0619-90 90 TABLET in 1 BOTTLE (72189-619-90) Gabapentin Direct_Rx 2025-03-18
72865-0255-05 500 TABLET in 1 BOTTLE (72865-255-05) GABAPENTIN XLCare Pharmaceuticals, Inc. 2021-10-01
72865-0255-90 90 TABLET in 1 BOTTLE (72865-255-90) GABAPENTIN XLCare Pharmaceuticals, Inc. 2021-10-01
72865-0256-05 500 TABLET in 1 BOTTLE (72865-256-05) GABAPENTIN XLCare Pharmaceuticals, Inc. 2021-10-01
72865-0256-90 90 TABLET in 1 BOTTLE (72865-256-90) GABAPENTIN XLCare Pharmaceuticals, Inc. 2021-10-01
72888-0131-00 1000 TABLET in 1 BOTTLE (72888-131-00) Gabapentin Advagen Pharma Ltd 2022-09-22
72888-0131-01 100 TABLET in 1 BOTTLE (72888-131-01) Gabapentin Advagen Pharma Ltd 2022-09-22
72888-0131-05 500 TABLET in 1 BOTTLE (72888-131-05) Gabapentin Advagen Pharma Ltd 2022-09-22
72888-0131-30 30 TABLET in 1 BOTTLE (72888-131-30) Gabapentin Advagen Pharma Ltd 2022-09-22
72888-0132-00 1000 TABLET in 1 BOTTLE (72888-132-00) Gabapentin Advagen Pharma Ltd 2022-09-22
72888-0132-01 100 TABLET in 1 BOTTLE (72888-132-01) Gabapentin Advagen Pharma Ltd 2022-09-22
72888-0132-05 500 TABLET in 1 BOTTLE (72888-132-05) Gabapentin Advagen Pharma Ltd 2022-09-22
72888-0132-30 30 TABLET in 1 BOTTLE (72888-132-30) Gabapentin Advagen Pharma Ltd 2022-09-22
76282-0405-01 100 TABLET, FILM COATED in 1 BOTTLE (76282-405-01) GABAPENTIN Exelan Pharmaceuticals Inc. 2012-11-02
76282-0405-05 500 TABLET, FILM COATED in 1 BOTTLE (76282-405-05) GABAPENTIN Exelan Pharmaceuticals Inc. 2012-11-02
76282-0405-30 30 TABLET, FILM COATED in 1 BOTTLE (76282-405-30) GABAPENTIN Exelan Pharmaceuticals Inc. 2012-11-02
76282-0405-90 90 TABLET, FILM COATED in 1 BOTTLE (76282-405-90) GABAPENTIN Exelan Pharmaceuticals Inc. 2012-11-02
76282-0406-01 100 TABLET, FILM COATED in 1 BOTTLE (76282-406-01) GABAPENTIN Exelan Pharmaceuticals Inc. 2012-11-02
76282-0406-05 500 TABLET, FILM COATED in 1 BOTTLE (76282-406-05) GABAPENTIN Exelan Pharmaceuticals Inc. 2012-11-02
76282-0406-30 30 TABLET, FILM COATED in 1 BOTTLE (76282-406-30) GABAPENTIN Exelan Pharmaceuticals Inc. 2012-11-02
76282-0406-90 90 TABLET, FILM COATED in 1 BOTTLE (76282-406-90) GABAPENTIN Exelan Pharmaceuticals Inc. 2012-11-02
76282-0706-05 500 TABLET in 1 BOTTLE (76282-706-05) GABAPENTIN Exelan Pharmaceuticals, Inc. 2021-10-01
76282-0706-90 90 TABLET in 1 BOTTLE (76282-706-90) GABAPENTIN Exelan Pharmaceuticals, Inc. 2021-10-01
76282-0707-05 500 TABLET in 1 BOTTLE (76282-707-05) GABAPENTIN Exelan Pharmaceuticals, Inc. 2021-10-01
Observed labelers: Bryant Ranch Prepack (75) · Proficient Rx LP (41) · Laurus Labs Limited (30) · Aphena Pharma Solutions - Tennessee, LLC (21) · Asclemed USA, Inc. (18) · DIRECT RX (16) · +43 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.